Roche Q1 Sales Decline Tempered by Swift Uptake of new Eye Drug
Q1 sales down 7 at 15.3 bln francs but above market view CEO says 432 mln francs in Vabysmo sales well above consensus 2023 core EPS decline still seen in low singledigit range Roche repeats COVID related sales will drop by 5 bln francs April 26 Reuters Switzerland39;s Roche said firstquarter sales dropped 7 on falling […]